Home Page - Hero Image with Call to Action - Join our Network
Medicare MS-DRG Payment Add-On for COVID-19 Hospitalizations
Univera Healthcare has updated the weighting factor of the assigned Medicare severity diagnosis-related group (MS-DRG) by 20 percent for COVID-19-related hospitalization claims processed on or after June 12, 2020, for our Medicare Advantage members.
Eyewear Benefit Clarification for MMC and HARP Members
Clarification of the eyewear benefit for Medicaid Managed Care (MMC) and Health and Recovery Plan (HARP) members related to standard vs. non-standard/deluxe frames and lenses.
Hyaluronic Acid Preferred Therapy Update
We want to make you aware of an upcoming change regarding treatment with hyaluronic acid therapy.
Effective October 1, 2020, Euflexxa, Synvisc, and Synvisc-One will be our preferred hyaluronic acid therapy products for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics.